Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis Imperfecta | 7 | 2025 | 172 | 2.030 |
Why?
|
| CADASIL | 1 | 2024 | 7 | 0.910 |
Why?
|
| Quality of Life | 5 | 2023 | 2163 | 0.860 |
Why?
|
| Phenylketonurias | 1 | 2023 | 14 | 0.840 |
Why?
|
| Hyperammonemia | 1 | 2023 | 62 | 0.810 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2023 | 85 | 0.770 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2022 | 14 | 0.770 |
Why?
|
| Neurodevelopmental Disorders | 5 | 2025 | 548 | 0.730 |
Why?
|
| Hinduism | 1 | 2021 | 1 | 0.720 |
Why?
|
| Thrombocytopenia | 1 | 2023 | 237 | 0.720 |
Why?
|
| Mythology | 1 | 2021 | 8 | 0.720 |
Why?
|
| Chromosome Disorders | 1 | 2023 | 316 | 0.710 |
Why?
|
| Developmental Disabilities | 2 | 2024 | 747 | 0.710 |
Why?
|
| tRNA Methyltransferases | 1 | 2021 | 5 | 0.710 |
Why?
|
| Leigh Disease | 1 | 2021 | 24 | 0.690 |
Why?
|
| Acidosis, Lactic | 1 | 2020 | 30 | 0.670 |
Why?
|
| Mutation | 8 | 2025 | 6350 | 0.670 |
Why?
|
| Liver Failure | 1 | 2021 | 91 | 0.660 |
Why?
|
| Critical Illness | 1 | 2024 | 629 | 0.650 |
Why?
|
| Otitis | 1 | 2019 | 11 | 0.630 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2019 | 24 | 0.620 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 256 | 0.620 |
Why?
|
| Receptors, Cholinergic | 1 | 2019 | 85 | 0.600 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2019 | 148 | 0.580 |
Why?
|
| Vocal Cord Paralysis | 1 | 2019 | 69 | 0.560 |
Why?
|
| Protein Biosynthesis | 1 | 2021 | 678 | 0.560 |
Why?
|
| Dwarfism | 1 | 2018 | 105 | 0.560 |
Why?
|
| Limb Deformities, Congenital | 1 | 2018 | 112 | 0.560 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 214 | 0.550 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 429 | 0.540 |
Why?
|
| Family | 2 | 2025 | 597 | 0.540 |
Why?
|
| Liver Transplantation | 2 | 2023 | 1122 | 0.540 |
Why?
|
| Craniosynostoses | 1 | 2019 | 134 | 0.530 |
Why?
|
| Hearing Loss | 1 | 2019 | 214 | 0.520 |
Why?
|
| Craniofacial Abnormalities | 1 | 2018 | 253 | 0.510 |
Why?
|
| Heterozygote | 1 | 2019 | 732 | 0.510 |
Why?
|
| Intellectual Disability | 2 | 2024 | 1096 | 0.510 |
Why?
|
| Urogenital Abnormalities | 1 | 2018 | 168 | 0.510 |
Why?
|
| Phenotype | 8 | 2025 | 4611 | 0.480 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 938 | 0.460 |
Why?
|
| Infant | 11 | 2024 | 13263 | 0.450 |
Why?
|
| Writing | 1 | 2014 | 65 | 0.420 |
Why?
|
| Humans | 36 | 2025 | 134225 | 0.400 |
Why?
|
| Psychotherapy | 1 | 2014 | 247 | 0.360 |
Why?
|
| Chronic Pain | 2 | 2024 | 149 | 0.350 |
Why?
|
| Child | 16 | 2025 | 25917 | 0.350 |
Why?
|
| Fractures, Bone | 2 | 2023 | 211 | 0.340 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2014 | 464 | 0.340 |
Why?
|
| Pediatrics | 1 | 2019 | 1221 | 0.330 |
Why?
|
| Adolescent | 12 | 2025 | 20647 | 0.310 |
Why?
|
| Pedigree | 2 | 2024 | 1732 | 0.290 |
Why?
|
| Adult | 13 | 2025 | 31962 | 0.290 |
Why?
|
| Male | 20 | 2025 | 66215 | 0.280 |
Why?
|
| Cohort Studies | 4 | 2024 | 5225 | 0.280 |
Why?
|
| Female | 21 | 2025 | 72054 | 0.260 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 4008 | 0.260 |
Why?
|
| Qualitative Research | 3 | 2025 | 648 | 0.250 |
Why?
|
| Autistic Disorder | 3 | 2025 | 376 | 0.230 |
Why?
|
| Receptor, Notch3 | 1 | 2024 | 12 | 0.230 |
Why?
|
| Child, Preschool | 9 | 2025 | 14897 | 0.220 |
Why?
|
| Adaptation, Psychological | 2 | 2025 | 455 | 0.220 |
Why?
|
| Receptors, AMPA | 1 | 2024 | 51 | 0.220 |
Why?
|
| Apoferritins | 1 | 2023 | 4 | 0.210 |
Why?
|
| Iron Metabolism Disorders | 1 | 2023 | 12 | 0.210 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2023 | 14 | 0.210 |
Why?
|
| Gain of Function Mutation | 1 | 2024 | 116 | 0.200 |
Why?
|
| Chromosome Breakage | 1 | 2023 | 166 | 0.200 |
Why?
|
| Membrane Transport Proteins | 1 | 2024 | 188 | 0.200 |
Why?
|
| Repressor Proteins | 2 | 2023 | 874 | 0.200 |
Why?
|
| Lipomatosis | 1 | 2023 | 16 | 0.200 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 162 | 0.200 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 76 | 0.200 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 296 | 0.200 |
Why?
|
| Facies | 1 | 2023 | 156 | 0.200 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 148 | 0.190 |
Why?
|
| Receptors, Glycine | 1 | 2022 | 17 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 393 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 259 | 0.190 |
Why?
|
| Pain Management | 1 | 2024 | 200 | 0.180 |
Why?
|
| Ataxia | 1 | 2022 | 177 | 0.180 |
Why?
|
| RNA, Transfer | 1 | 2021 | 77 | 0.170 |
Why?
|
| Sudden Infant Death | 1 | 2020 | 36 | 0.170 |
Why?
|
| Cysteine | 1 | 2021 | 143 | 0.160 |
Why?
|
| Acetylcysteine | 1 | 2021 | 86 | 0.160 |
Why?
|
| Young Adult | 6 | 2025 | 9963 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 396 | 0.160 |
Why?
|
| Hyperlactatemia | 1 | 2019 | 2 | 0.160 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 332 | 0.160 |
Why?
|
| Thiamine | 1 | 2019 | 10 | 0.160 |
Why?
|
| Acidosis | 1 | 2021 | 104 | 0.160 |
Why?
|
| Caregivers | 1 | 2025 | 594 | 0.160 |
Why?
|
| Actin Cytoskeleton | 1 | 2019 | 49 | 0.160 |
Why?
|
| Philadelphia | 1 | 2019 | 27 | 0.160 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 244 | 0.150 |
Why?
|
| Middle Ear Ventilation | 1 | 2019 | 35 | 0.150 |
Why?
|
| Self Report | 1 | 2022 | 553 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 1167 | 0.150 |
Why?
|
| Codon, Nonsense | 1 | 2019 | 144 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 478 | 0.150 |
Why?
|
| Pulmonary Alveoli | 1 | 2019 | 142 | 0.140 |
Why?
|
| Osteogenesis, Distraction | 1 | 2019 | 57 | 0.140 |
Why?
|
| Testis | 1 | 2020 | 433 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 284 | 0.140 |
Why?
|
| Siblings | 1 | 2019 | 203 | 0.140 |
Why?
|
| Shock, Septic | 1 | 2019 | 157 | 0.140 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2019 | 90 | 0.140 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 217 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2021 | 301 | 0.140 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 121 | 0.140 |
Why?
|
| Seizures | 1 | 2022 | 892 | 0.140 |
Why?
|
| Drosophila | 1 | 2022 | 829 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2024 | 1105 | 0.130 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 3119 | 0.130 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 209 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2019 | 427 | 0.130 |
Why?
|
| Motor Activity | 1 | 2019 | 531 | 0.130 |
Why?
|
| Middle Aged | 7 | 2025 | 29430 | 0.120 |
Why?
|
| Mitochondria | 1 | 2021 | 759 | 0.120 |
Why?
|
| Recurrence | 1 | 2019 | 1470 | 0.120 |
Why?
|
| Disease Management | 1 | 2019 | 567 | 0.120 |
Why?
|
| Parents | 1 | 2022 | 1072 | 0.120 |
Why?
|
| Gene Expression | 1 | 2019 | 1622 | 0.110 |
Why?
|
| Myocardium | 1 | 2019 | 1041 | 0.110 |
Why?
|
| Education | 1 | 2014 | 111 | 0.110 |
Why?
|
| Comorbidity | 1 | 2019 | 1628 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 1351 | 0.110 |
Why?
|
| Interviews as Topic | 2 | 2025 | 428 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 1885 | 0.090 |
Why?
|
| Lung | 1 | 2019 | 1578 | 0.090 |
Why?
|
| Peroxisomes | 1 | 2011 | 42 | 0.090 |
Why?
|
| Arabidopsis Proteins | 1 | 2011 | 60 | 0.090 |
Why?
|
| Arabidopsis | 1 | 2011 | 94 | 0.080 |
Why?
|
| Stroke | 1 | 2018 | 1079 | 0.080 |
Why?
|
| Prognosis | 1 | 2019 | 5085 | 0.080 |
Why?
|
| Epilepsy | 2 | 2025 | 898 | 0.070 |
Why?
|
| Texas | 1 | 2014 | 3719 | 0.060 |
Why?
|
| Genomics | 2 | 2024 | 1678 | 0.060 |
Why?
|
| Ethanolamine | 1 | 2024 | 8 | 0.060 |
Why?
|
| Seizures, Febrile | 1 | 2025 | 29 | 0.060 |
Why?
|
| Choline | 1 | 2024 | 56 | 0.060 |
Why?
|
| Alleles | 2 | 2024 | 1724 | 0.060 |
Why?
|
| Receptors, Virus | 1 | 2024 | 111 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 94 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1621 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2025 | 244 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2023 | 103 | 0.050 |
Why?
|
| Ferritins | 1 | 2023 | 109 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2024 | 207 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 239 | 0.050 |
Why?
|
| Social Support | 1 | 2025 | 389 | 0.050 |
Why?
|
| Uncertainty | 1 | 2023 | 104 | 0.050 |
Why?
|
| Diphosphonates | 1 | 2022 | 43 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2025 | 238 | 0.050 |
Why?
|
| Fear | 1 | 2023 | 205 | 0.050 |
Why?
|
| Mice | 3 | 2025 | 19049 | 0.050 |
Why?
|
| Animals | 4 | 2025 | 36526 | 0.040 |
Why?
|
| Amish | 1 | 2020 | 11 | 0.040 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2021 | 76 | 0.040 |
Why?
|
| Iron | 1 | 2023 | 305 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 360 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 623 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 21822 | 0.040 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 52 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1088 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2019 | 165 | 0.040 |
Why?
|
| Cognition | 1 | 2024 | 819 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 400 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2023 | 804 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 748 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 2019 | 60 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 251 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 657 | 0.040 |
Why?
|
| Syndrome | 1 | 2021 | 1176 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 81 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2019 | 378 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2018 | 195 | 0.030 |
Why?
|
| Creatinine | 1 | 2019 | 418 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8640 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 4012 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 390 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2019 | 485 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1303 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2019 | 337 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 795 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 475 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3759 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 3509 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 390 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7600 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7244 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 11196 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2915 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 13105 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 17591 | 0.010 |
Why?
|